Advertisement
UK markets close in 2 hours 41 minutes
  • FTSE 100

    8,086.15
    +41.34 (+0.51%)
     
  • FTSE 250

    19,807.65
    +7.93 (+0.04%)
     
  • AIM

    755.20
    +0.33 (+0.04%)
     
  • GBP/EUR

    1.1639
    +0.0011 (+0.09%)
     
  • GBP/USD

    1.2434
    -0.0018 (-0.15%)
     
  • Bitcoin GBP

    53,390.29
    +402.18 (+0.76%)
     
  • CMC Crypto 200

    1,439.24
    +15.14 (+1.06%)
     
  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     
  • DOW

    38,503.69
    +263.71 (+0.69%)
     
  • CRUDE OIL

    83.05
    -0.31 (-0.37%)
     
  • GOLD FUTURES

    2,331.90
    -10.20 (-0.44%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     
  • DAX

    18,176.17
    +38.52 (+0.21%)
     
  • CAC 40

    8,144.56
    +38.78 (+0.48%)
     

BUZZ-Smith & Nephew: top FTSE 100 losers after Barclays downgrade

** Shares (Berlin: DI6.BE - news) in Smith & Nephew (Frankfurt: 502816 - news) , Europe's largest maker of artificial hips and knees, down 1.3 pct and bottom of the FTSE 100

** Barclays (LSE: BARC.L - news) cuts rating on stock to "equal-weight" from "overweight", raises PT to 1240p from 1230p

** Analysts say results continue to disappoint, add management transition could delay key initiatives

** Smith & Nephew reported H1 trading profit down 3 pct last month, dragged by China

** Analysts say while disappointments in co's Emerging Markets and Wound Care units are set to dissipate, there remain risks from a "resurgent" Zimmer Biomet (NYSE: ZBH - news)

** Of 19 analysts covering stock, 10 have "buy" or higher, 9 have "hold"; median PT of 1,267p implies 1 pct downside (venkateshasoumithri.mamidipudi.thomsonreuters.com@reuters.net)